Paul
03-13-2004, 02:48 PM
According to results presented at the 2003 San Antonio Breast Cancer Symposium the investigational agent Abraxane™ (ABI-007) produced higher response rates and improved time to cancer progression compared to Taxol® in metastatic breast cancer.